Segments

We have the definitive database of repertoires from multiple species. Contact us for collaboration opportunities, or view our next generation antibody discover libraries designed from natural fitness landscapes.
Structures

We maintain a massive database of all antibody and TCR solved structures and structural models. See below for a helpful collection of solved structures for monoclonal therapeutics. For a larger collection of all solved structures of antibodies and immunoglobulin super domains, see the complete list

pertuzumab [1s78]
cetuximab [1yy8]
rituximab [2osl]
omalizumab [2xa8]
matuzumab [3c08]
efalizumab [3eo9]
ofatumumab [3giz]
nimotuzumab [3gkw]
ustekinumab [3hmw]
sonepcizumab [3i9g]
basiliximab [3iu3]
motavizumab [3ixt]
daclizumab [3nfp]
ibalizumab [3o2d]
motavizumab [3qwo]
ponezumab [3u0t]
anti-dengue [3uyp]
anti-dengue [3uze]
adalimumab [3wd5]
olokizumab [4cni]
tanezumab [4edw]
infliximab [4g3y]
canakinumab [4g5z]
gevokizumab [4g6k]
trastuzumab [4hjg]
trastuzumab [4hkz]
lebrikizumab [4i77]
trastuzumab [4ioi]
natalizumab [4irz]
motavizumab [4jlr]
onartuzumab [4k3j]
cetuximab [4kro]
pertuzumab [4llu]
bezlotoxumab [4np4]
drozitumab [4od2]
Research

We have build our leadership in repertoire analysis and engineering through a decade of aggressive research and publication. See a complete selection of our publications.